Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/29416
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lechermann, LM | - |
dc.contributor.author | Lau, D | - |
dc.contributor.author | Attili, B | - |
dc.contributor.author | Aloj, L | - |
dc.contributor.author | Gallagher, FA | - |
dc.date.accessioned | 2024-07-26T06:26:17Z | - |
dc.date.available | 2024-07-26T06:26:17Z | - |
dc.date.issued | 2021-08-11 | - |
dc.identifier | ORCiD: Laura M. Lechermann https://orcid.org/0000-0002-2742-6269 | - |
dc.identifier | ORCiD: Doreen Lau https://orcid.org/0000-0002-7623-2401 | - |
dc.identifier | ORCiD: Luigi Aloj https://orcid.org/0000-0002-7452-4961 | - |
dc.identifier | ORCiD: Ferdia A. Gallagher https://orcid.org/0000-0003-4784-5230 | - |
dc.identifier | 4042 | - |
dc.identifier.citation | Lechermann, L.M. et al. (2021) 'In vivo cell tracking using pet: Opportunities and challenges for clinical translation in oncology', Cancers, 13 (16), 4042, pp. 1 - 19. doi: 10.3390/cancers13164042. | en_US |
dc.identifier.uri | https://bura.brunel.ac.uk/handle/2438/29416 | - |
dc.description | Data Availability Statement: Not applicable. | en_US |
dc.description.abstract | Cell therapy is a rapidly evolving field involving a wide spectrum of therapeutic cells for personalised medicine in cancer. In vivo imaging and tracking of cells can provide useful information for improving the accuracy, efficacy, and safety of cell therapies. This review focuses on radiopharmaceuticals for the non-invasive detection and tracking of therapeutic cells using positron emission tomography (PET). A range of approaches for imaging therapeutic cells is discussed: Direct ex vivo labelling of cells, in vivo indirect labelling of cells by utilising gene reporters, and detection of specific antigens expressed on the target cells using antibody-based radiopharmaceuticals (immuno-PET). This review examines the evaluation of PET imaging methods for therapeutic cell tracking in preclinical cancer models, their role in the translation into patients, first-in-human studies, as well as the translational challenges involved and how they can be overcome. | en_US |
dc.description.sponsorship | L.M.L. and F.A.G. have research grants from CRUK (C19212/A16628, C19212/A911376) and GlaxoSmithKline (RQAG/092). | en_US |
dc.format.extent | 1 - 19 | - |
dc.format.medium | Electronic | - |
dc.language | English | - |
dc.language.iso | en_US | en_US |
dc.publisher | MDPI | en_US |
dc.rights | Copyright © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.subject | cell therapy | en_US |
dc.subject | immunotherapy | en_US |
dc.subject | cell tracking | en_US |
dc.subject | PET/CT | en_US |
dc.subject | PET/MRI | en_US |
dc.subject | direct cell labelling | en_US |
dc.subject | reporter genes | en_US |
dc.subject | immuno-PET | en_US |
dc.title | In vivo cell tracking using pet: Opportunities and challenges for clinical translation in oncology | en_US |
dc.type | Article | en_US |
dc.date.dateAccepted | 2021-08-05 | - |
dc.identifier.doi | https://doi.org/10.3390/cancers13164042 | - |
dc.relation.isPartOf | Cancers | - |
pubs.issue | 16 | - |
pubs.publication-status | Published | - |
pubs.volume | 13 | - |
dc.identifier.eissn | 2072-6694 | - |
dc.rights.license | https://creativecommons.org/licenses/by/4.0/legalcode.en | - |
dc.rights.holder | The authors | - |
Appears in Collections: | Dept of Life Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | Copyright © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). | 2.63 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License